Phase 2, Parallel???Arm Study of MGCD265 in Patients wit

Project: Research project

Description

Phase 2, Parallel???Arm Study of MGCD265 in Patients with Locally Advanced or Metastatic Non???Small Cell Lung Cancer with Activating Genetic Alterations in Mesenchymal???Epithelial Transition Factor
StatusFinished
Effective start/end date9/1/153/14/18

Funding

  • MIRATI THERAPEUTICS, INC.

Fingerprint

Small Cell Lung Carcinoma